Related Experiment Video
Updated: Aug 17, 2026

06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
Response of carcinoma of unknown primary site affecting bone to thalidomide
Richard C Frank1, Fred Kaplan, Saraswathi Nair
1Department of Medical Oncology and Haematology, Whittingham Cancer Center, Norwalk Hospital, 24 Stevens Street, Norwalk, CT 06856, USA. richard.frank@norwalkhealth.org
The Lancet. Oncology
|July 5, 2005
Abstract
No abstract available in PubMed .
Related Concept Videos
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
